Parent Page: Directory id: 22535 Active Page: Detailsid:23325



Bryan P. White, Pharm. D., BCPS, BCIDP
Internal Medicine

Bryan P. White, Pharm. D., BCPS, BCIDP

Clinical Instructor (Volunteer Faculty)

700 NE 13th St.
Oklahoma City, OK  73104

405-271-8001 ext 33392

Dr. White is currently an Infectious Diseases Clinical Pharmacist at the University of Oklahoma Medical Center.  He works with the inpatient consult service, antimicrobial stewardship, and the outpatient parenteral antibiotic therapy program. His research interests include antimicrobial stewardship, resistant gram negative infections, and bloodstream infections.

Academic Section(s):

Infectious Diseases


2012     Doctor of Pharmacy
              University of Georgia, Athens, GA


2015 - 2016    PGY-2 Infectious Disease Pharmacy Residency
                         University of Mississippi Medical Center
                         Jackson, MS

2014 - 2015     PGY-1 Pharmacy Residency
                          Albany Medical Center
                          Albany, NY

Clinical/Research Interests:

Antimicrobial stewardship, rapid diagnostic technologies, and resistant gram-negative infections

Select Publications:

White BP, Lomaestro B, Pai MP. Optimizing the initial amikacin dosage in adults. Antimicrob Agents Chemother. 2015;59(11):7094-7096. doi:10.1128/AAC.01032-15

White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21(9):1208-1209. doi:10.1016/S1473-3099(21)00456-4

Fleming VH, White BP, Southwood R. Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. Am J Emerg Med. 2014;32(8):864-870. doi:10.1016/j.ajem.2014.04.033

White BP, Patel S, Tsui J, Chastain DB. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections. Infect Dis (Lond). 2019;51(3):161-167. doi:10.1080/23744235.2018.1527470

White BP, Stover KR, Barber KE, Galloway RC, Sullivan DC, King ST. Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp. Int J Antimicrob Agents. 2017;50(5):690-692. doi:10.1016/j.ijantimicag.2017.05.010

White BP, Barber KE, Chastain DB. Variation among infectious diseases pharmacists for the treatment of staphylococcus aureus bacteremia. J Pharm Pract. Published online August 16, 2021:8971900211038864. doi:10.1177/08971900211038864